skip to Main Content

ABOUT           BLOG

ABOUT

Manzo Pharmaceuticals, Inc. (OTC: MNZO)

Robert Ritch has always respected and studied Warren Buffets techniques and planned to implement them in his version and therefore has purchased the controlling block of preferred shares of Manzo Pharmaceuticals, Inc. (OTC: MNZO) and taken the position of President with the firm. Robert Ritch stated the first steps would be to bring the companies filing up to date and then acquire in whole or in part operating companies. There will also be a name change, but the new name has not been finalized or filed for at this time. The currently planned verticals are energy, technology, real estate and financial services.

Questions & Comments About MNZO

BLOG

Recent Posts

MNZO update September 1, 2017 with President Robert Ritch

  This week we made some serious progress and some setbacks Simple Marketing Inc. is…

Read More

MNZO update August 25, 2017 with President Robert Ritch

This week we made progress with several acquisition targets and added some new ones. Simple…

Read More

MNZO update August 18 2017 by President Robert Ritch

This week we made progress with several acquisition targets and added some new ones. The…

Read More

MNZO August 11 2017 report with President Robert Ritch

Robert Ritch Manzo Pharmaceuticals, Inc. 615-241-5241 rob@robertritch.com MNZO Weekly Update August 11, 2017 President Robert Ritch provides…

Read More